Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-14
2005-06-14
Barts, Samuel (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C564S336000, C564S355000, C564S424000, C564S425000, C564S360000
Reexamination Certificate
active
06906087
ABSTRACT:
Crystalline forms of Venlafaxine hydrochloride were found, referred to hereinafter as polymorphic Forms A, B and D. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and pharmaceutical compositions comprising the crystalline forms.
REFERENCES:
patent: 5043466 (1991-08-01), Shepard
patent: 2002/0143211 (2002-10-01), Dolitzky et al.
patent: 2002/0183553 (2002-12-01), Dolitzky et al.
patent: 2003/0105359 (2003-06-01), Van Der Schaaf et al.
patent: 2003/0109585 (2003-06-01), Ali et al.
patent: 0112669 (1984-07-01), None
patent: 0444855 (1991-09-01), None
patent: 02/45658 (2002-06-01), None
patent: 02/46140 (2002-06-01), None
J. Yardley et al., J. Med. Chem. (1990), vol. 33, pp. 2899-2905.
Freiermuth Beat
Marcolli Claudia
Szelagiewicz Martin
Van Der Schaaf Paul Adriaan
Barts Samuel
Ciba Specialty Chemicals Corpation
Mansfield Kevin T.
LandOfFree
Crystalline forms of venlafaxine hydrochloride does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of venlafaxine hydrochloride, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of venlafaxine hydrochloride will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3522528